Design and immunogenicity of a novel synthetic antigen based on the ligand domain of the Plasmodium vivax Duffy binding protein

Clinical and Vaccine Immunology

Volumn 19, Issue 1, 2012, Pages 30-36

  Ntumngia, Francis B ^a   Adams, John H ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DEKNULL ANTIGEN; DUFFY BINDING PROTEIN; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ANTIGEN BINDING; ARTICLE; DRUG DESIGN; ERYTHROCYTE; GENE EXPRESSION; GENETIC POLYMORPHISM; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; NULL ALLELE; PLASMODIUM VIVAX; PRIORITY JOURNAL; PROTEIN DOMAIN; RAT;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, B-LYMPHOCYTE; ERYTHROCYTES; HUMANS; IMMUNOBLOTTING; IMMUNODOMINANT EPITOPES; MALARIA VACCINES; MOLECULAR SEQUENCE DATA; PLASMODIUM VIVAX; PROTEIN BINDING; PROTOZOAN PROTEINS; RATS; RECEPTORS, CELL SURFACE; VACCINES, SYNTHETIC;

EID: 84855675918     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05466-11     Document Type: Article

References (45)

1. Adams JH, et al. 1990. The Duffy receptor family of Plasmodium knowlesi is located within the micronemes of invasive malaria merozoites. Cell 63:141-153.
2. Adams JH, et al. 1992. A family of erythrocyte binding proteins of malaria parasites. Proc. Natl. Acad. Sci. U. S. A. 89:7085-7089.
3. Aikawa M, Miller LH, Johnson J, Rabbege J. 1978. Erythrocyte entry by malarial parasites. A moving junction between erythrocyte and parasite. J. Cell Biol. 77:72-82. (Pubitemid 8321757)
4. Ampudia E, Patarroyo MA, Patarroyo ME, Murillo LA. 1996. Genetic polymorphism of the Duffy receptor binding domain of Plasmodium vivax in Colombian wild isolates. Mol. Biochem. Parasitol. 78:269-272.
5. Barnwell JW, Wertheimer SP. 1989. Plasmodium vivax: merozoite antigens, the Duffy blood group, and erythrocyte invasion. Prog. Clin. Biol. Res. 313:1-11.
6. Barouch DH. 2007. HIV-1 vaccine candidate ineffective. AIDS Clin. Care 19:93.
7. Batchelor JD, Zahm JA, Tolia NH. 2011. Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARC. Nat. Struct. Mol. Biol. 18:908-914.
8. Camus D, Hadley TJ. 1985. A Plasmodium falciparum antigen that binds to host erythrocytes and merozoites. Science 230:553-556. (Pubitemid 16169810)
9. Ceravolo IP, et al. 2009. Naturally acquired inhibitory antibodies to Plasmodium vivax Duffy binding protein are short-lived and allele-specific following a single malaria infection. Clin. Exp. Immunol. 156:502-510.
10. Chitnis CE, Chaudhuri A, Horuk R, Pogo AO, Miller LH. 1996. The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytes. J. Exp. Med. 184:1531-1536. (Pubitemid 26354709)
11. Chitnis CE, Miller LH. 1994. Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasion. J. Exp. Med. 180:497-506. (Pubitemid 24224126)
12. Chootong P, et al. 2010. Mapping epitopes of the Plasmodium vivax Duffy binding protein with naturally acquired inhibitory antibodies. Infect. Immun. 78:1089-1095.
13. Cole-Tobian J, King CL. 2003. Diversity and natural selection in Plasmodium vivax Duffy binding protein gene. Mol. Biochem. Parasitol. 127:121-132. (Pubitemid 36369687)
14. Dutta S, Daugherty JR, Ware LA, Lanar DE, Ockenhouse CF. 2000. Expression, purification and characterization of a functional region of the Plasmodium vivax Duffy binding protein. Mol. Biochem. Parasitol. 109:179-184. (Pubitemid 30665415)
15. Dvorak JA, Miller LH, Whitehouse WC, Shiroishi T. 1975. Invasion of erythrocytes by malaria merozoites. Science 187:748-750.
16. Fraser T, et al. 1997. Expression and serologic activity of a soluble recombinant Plasmodium vivax Duffy binding protein. Infect. Immun. 65:2772-2777. (Pubitemid 27264107)
17. Grimberg BT, et al. 2007. Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding protein. PLoS Med. 4:e337.
18. Hans D, et al. 2005. Mapping binding residues in the Plasmodium vivax domain that binds Duffy antigen during red cell invasion. Mol. Microbiol. 55:1423-1434 . (Pubitemid 40342070)
19. Haynes JD, et al. 1988. Receptor-like specificity of a Plasmodium knowlesi malarial protein that binds to Duffy antigen ligands on erythrocytes. J. Exp. Med. 167:1873-1881.
20. Horuk R, et al. 1993. A receptor for the malarial parasite Plasmodium vivax: the erythrocyte chemokine receptor. Science 261:1182-1184. (Pubitemid 23300887)
21. King CL, et al. 2008. Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infection. Proc. Natl. Acad. Sci. U. S. A. 105:8363-8368. (Pubitemid 351904761)
22. Liang H, Sim BK. 1997. Conservation of structure and function of the erythrocyte-binding domain of Plasmodium falciparum EBA-175. Mol. Biochem. Parasitol. 84:241-245. (Pubitemid 27092986)
23. Mayer DC, et al. 2004. Polymorphism in the Plasmodium falciparum erythrocyte-binding ligand JESEBL/EBA-181 alters its receptor specificity. Proc. Natl. Acad. Sci. U. S. A. 101:2518-2523. (Pubitemid 38269343)
24. McHenry AM, Barnes SJ, Ntumngia FB, King CL, Adams JH. 2011. Determination of the molecular basis for a limited dimorphism, N417K, in the Plasmodium vivax Duffy-binding protein. PLoS One 6:e20192.
25. Michon P, Fraser T, Adams JH. 2000. Naturally acquired and vaccine-elicited antibodies block erythrocyte cytoadherence of the Plasmodium vivax Duffy binding protein. Infect. Immun. 68:3164-3171. (Pubitemid 30340405)
26. Michon P, et al. 2001. Duffy-null promoter heterozygosity reduces DARC expression and abrogates adhesion of the P. vivax ligand required for blood-stage infection. FEBS Lett. 495:111-114. (Pubitemid 32367983)
27. Miller LH, Mason SJ, Clyde DF, McGinniss MH. 1976. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N. Engl. J. Med. 295:302-304.
28. Miller LH, Mason SJ, Dvorak JA, McGinniss MH, Rothman IK. 1975. Erythrocyte receptors for (Plasmodium knowlesi) malaria: Duffy blood group determinants. Science 189:561-563.
29. Ntumngia FB, et al. 2009. Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development. Am. J. Trop. Med. Hyg. 80:218-227.
30. Ranjan A, Chitnis CE. 1999. Mapping regions containing binding residues within functional domains of Plasmodium vivax and Plasmodium knowlesi erythrocyte-binding proteins. Proc. Natl. Acad. Sci. U. S. A. 96: 14067-14072.
31. Singh S, et al. 2001. Biochemical, biophysical, and functional characterization of bacterially expressed and refolded receptor binding domain of Plasmodium vivax Duffy-binding protein. J. Biol. Chem. 276: 17111-17116.
32. Smith DJ, et al. 2004. Mapping the antigenic and genetic evolution of influenza virus. Science 305:371-376. (Pubitemid 38938148)
33. Tobin GJ, et al. 2008. Deceptive imprinting and immune refocusing in vaccine design. Vaccine 26:6189-6199.
34. Tran TM, et al. 2005. Detection of a Plasmodium vivax erythrocyte binding protein by flow cytometry. Cytometry A 63:59-66. (Pubitemid 40194280)
35. Tsuboi T, et al. 1994. Natural variation within the principal adhesion domain of the Plasmodium vivax Duffy binding protein. Infect. Immun. 62:5581-5586. (Pubitemid 24365004)
36. Udomsangpetch R, Kaneko O, Chotivanich K, Sattabongkot J. 2008. Cultivation of Plasmodium vivax. Trends Parasitol. 24:85-88.
37. VanBuskirk KM, et al. 2004. Antigenic drift in the ligand domain of Plasmodium vivax Duffy binding protein confers resistance to inhibitory antibodies. J. Infect. Dis. 190:1556-1562. (Pubitemid 39411003)
38. VanBuskirk KM, Sevova E, Adams JH. 2004. Conserved residues in the Plasmodium vivax Duffy-binding protein ligand domain are critical for erythrocyte receptor recognition. Proc. Natl. Acad. Sci. U. S. A. 101:15754-15759. (Pubitemid 39473560)
39. Walker BD, Burton DR. 2008. Toward an AIDS vaccine. Science 320:760-764. (Pubitemid 351929619)
40. Welch SG, McGregor IA, Williams K. 1977. The Duffy blood group and malaria prevalence in Gambian West Africans. Trans. R. Soc. Trop. Med. Hyg. 71:295-296. (Pubitemid 8164439)
41. Welsh RM, Fujinami RS. 2007. Pathogenic epitopes, heterologous immunity and vaccine design. Nat. Rev. Microbiol. 5:555-563. (Pubitemid 46925383)
42. Wickramarachchi T, Devi YS, Mohammed A, Chauhan VS. 2008. Identification and characterization of a novel Plasmodium falciparum merozoite apical protein involved in erythrocyte binding and invasion. PLoS One 3:e1732.
43. Xainli J, Adams JH, King CL. 2000. The erythrocyte binding motif of Plasmodium vivax Duffy binding protein is highly polymorphic and functionally conserved in isolates from Papua New Guinea. Mol. Biochem. Parasitol. 111:253-260. (Pubitemid 32121669)
44. Yazdani SS, Shakri AR, Chitnis CE. 2004. A high cell density fermentation strategy to produce recombinant malarial antigen in E. coli. Biotechnol. Lett. 26:1891-1895. (Pubitemid 40181260)
45. Yazdani SS, Shakri AR, Mukherjee P, Baniwal SK, Chitnis CE. 2004. Evaluation of immune responses elicited in mice against a recombinant malaria vaccine based on Plasmodium vivax Duffy binding protein. Vaccine 22:3727-3737. (Pubitemid 39099649)